CompletedPhase 2NCT02164253

Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients

Studying Dietary iron overload disease

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University Hospital, Lille
Principal Investigator: Caroline Moreau, MD
UH Lille
Intervention: Deferiprone(drug)
Enrollment: 23 enrolled
Eligibility: 18-85 years · All sexes
Timeline: 2013 – 2016

Study locations (1)

Hôpital Roger Salengro, CHRU de Lille, Lille, France

Collaborators

ApoPharma

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02164253 on ClinicalTrials.gov

Other trials for Dietary iron overload disease

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07028112
Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.
Assistance Publique - Hôpitaux de Paris

See all trials for Dietary iron overload disease →

← Back to all trials